LYNDAL K. HESTERBERG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LYNDAL K. HESTERBERG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LYNDAL K. HESTERBERG. LYNDAL K. HESTERBERG is a Chief Scientific Officer in OncoCyte Corp ($OCX) and a CSO in OncoCyte Corp ($OCX) and a Sr VP, Research & Development in OncoCyte Corp ($OCX).
Address: 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA 94501 CA
Companies in which LYNDAL K. HESTERBERG is an Insider
OncoCyte Corp
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of LYNDAL K. HESTERBERG: CSO, Chief Scientific Officer, Sr VP, Research & Development
Holdings: 7,477 shares
Current Value: $40,750
Latest Transaction: Dec 15 2020
$OCX Market Capitalization: $159.33M
$OCX Previous Close: $5.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of LYNDAL K. HESTERBERG
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15 2020 | OCX | OncoCyte Corp | HESTERBERG LYNDAL K. | CSO | Grant | A | 0.00 | 6,603 | 0 | 7,477 | 874 to 7.5 K (+755.49 %) |
| Mar 18 2019 | OCX | OncoCyte Corp | HESTERBERG LYNDAL K. | Chief Scientific Of ... | Option Exercise | A | 3.52 | 350,000 | 1,232,000 | 350,000 | |
| Jul 31 2018 | OCX | OncoCyte Corp | HESTERBERG LYNDAL K. | Sr VP, Research & D ... | Option Exercise | P | 3.00 | 874 | 2,622 | 874 | |
| Jul 31 2018 | OCX | OncoCyte Corp | HESTERBERG LYNDAL K. | Sr VP, Research & D ... | Buy | P | 0.00 | 874 | 0 | 874 | 0 to 874 |
| Jul 31 2018 | OCX | OncoCyte Corp | HESTERBERG LYNDAL K. | Sr VP, Research & D ... | Option Exercise | P | 3.00 | 874 | 2,622 | 874 | |
| Jul 31 2018 | OCX | OncoCyte Corp | HESTERBERG LYNDAL K. | Sr VP, Research & D ... | Buy | P | 0.00 | 874 | 0 | 874 | 0 to 874 |
| Jun 04 2018 | OCX | OncoCyte Corp | HESTERBERG LYNDAL K. | Sr VP, Research & D ... | Option Exercise | A | 2.35 | 150,000 | 352,500 | 150,000 |